NNNN
NASDAQ HealthcareAnbio Biotechnology - Class A Ordinary Shares
Medical Instruments & Supplies
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
๐ Market Data
| Price | $8.48 |
|---|---|
| Volume | 1,286,438 |
| Market Cap | 372.42M |
| RSI (14-Day) | 40.1 |
| 200-Day MA | $23.41 |
| 50-Day MA | $12.61 |
| 52-Week High | $54.95 |
| 52-Week Low | $7.08 |
| P/E Ratio | 56.57 |
| Price / Book | 12.35 |
๐ฏ Investment Strategy Scores
NNNN scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (99/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Institutional Whale (9/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find NNNN in your text
Paste any article, transcript, or post โ the tool will extract NNNN and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.